$heff's $tation of $tocks & $olid DD

[$heff]

$New Economy Portfolio..exited a position in a stock that got an approval for their Intercepts Blood system for Convalescent Ebola.

Alert..exited $CERS at $4.52 in pre-mkt from $4.23 in New Economy Portfolio for a solid trade of 8% gain. (Link post below)

http://www.cerus.com/Investors/Press-Releases/Press-Release-Details/2014/FDA-Accepts-IDE-Supplement-for-INTERCEPT-Blood-System-Treatment-of-Ebola-Convalescent-Plasma/default.aspx

Disclaimer:.. http://bit.ly/OlN9DB

________________________________________________________________

Message in reply to:

New Economy Portfolio..entered a position in a stock that I had a 10% gain in last entry. Have traded in and out of this stock for solid gains.

Alert..entered $CERS at $4.23 in New Economy Portfolio for a potentially solid trade.

Waiting for news to come out regarding the IDE for INTERCEPT for the treatment of Ebola convalescent plasma. There is also an AD-COM Mtng on Dec 3rd with the Blood Advisory Committee.
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm419754.htm

On December 3, 2014, the Blood Products Advisory Committee will be seated as a device classification panel. In open session, the panel will discuss the appropriate device classification of blood establishment computer software (BECS) and accessories to BECS. Blood establishment computer software is currently subject to the premarket notification (510(k)) provisions of the Federal Food, Drug, and Cosmetic Act. In the afternoon, an informational presentation will be made regarding the emergence of chikungunya virus infections in the Western Hemisphere and potential implications for blood transfusion safety. The Committee will also hear an informational presentation on the first survey of the Rapid Donor Surveillance (RapidDOS) project on Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV)

Disclaimer:.. http://bit.ly/OlN9DB